News Desk, Amar Ajala, New Delhi
Published by: Nirmal Kant
Updated Mon, 27 Jun 2022 09:06 PM IST
hear the news
Permitting Cobavax as a booster for those who are fully vaccinated against COVID-19 with Kovashield or Covaxin is likely to be considered by the NTAGI (National Technical Advisory Group on Immunization), which will meet on Tuesday. Is gonna. Sources gave this information.
The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precautionary dose for people aged 18 years and above. India’s first indigenously developed RBD protein subunit vaccine Corbevax is currently being used to vaccinate children in the age group of 12 to 14 years.
“NTAGI will discuss allowing Corbevax, which has been approved by DCGI as a booster for those fully vaccinated with Covishield or Covaxin,” said a source.
The government advisory panel is also expected to review trial data for the quadrivalent human papillomavirus (qHPV) vaccine developed by the country’s first Serum Institute of India against cervical cancer.